ExoZymes Inc. Files 8-K for Material Agreement
Ticker: EXOZ · Form: 8-K · Filed: Jun 26, 2025 · CIK: 2010788
| Field | Detail |
|---|---|
| Company | Exozymes Inc. (EXOZ) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-filing, company-update
TL;DR
ExoZymes Inc. just filed an 8-K for a material agreement - big news coming.
AI Summary
ExoZymes Inc. filed an 8-K on June 26, 2025, reporting the entry into a material definitive agreement and financial statements. The company, formerly Invizyne Technologies Inc. until February 5, 2024, is incorporated in Nevada and operates in the biological products sector. Its principal executive offices are located in Monrovia, California.
Why It Matters
This filing indicates a significant business development for ExoZymes Inc., potentially impacting its operations and financial standing.
Risk Assessment
Risk Level: medium — The filing of a material definitive agreement suggests a significant event, but the lack of specific details about the agreement itself warrants a medium risk assessment.
Key Numbers
- 001-42204 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-4550057 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- EXOZYMES INC. (company) — Registrant
- Invizyne Technologies Inc (company) — Former Company Name
- June 26, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- Monrovia, CA (location) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by ExoZymes Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
When did ExoZymes Inc. change its name from Invizyne Technologies Inc.?
The company's name was changed from Invizyne Technologies Inc. on February 5, 2024.
What is ExoZymes Inc.'s standard industrial classification?
ExoZymes Inc. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
Where are ExoZymes Inc.'s principal executive offices located?
The principal executive offices of ExoZymes Inc. are located at 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016.
What is the fiscal year end for ExoZymes Inc.?
The fiscal year end for ExoZymes Inc. is December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding EXOZYMES INC. (EXOZ).